Still, there is no proof that these changes always happen
Patients should be counseled to report severe abdominal pain immediately Gallbladder disease : Increased risk of cholelithiasis and cholecystitis, likely related to rapid weight loss Hypoglycemia : Risk is low when used alone but increases when combined with insulin or sulfonylureas Thyroid C-cell tumors : Based on rodent studies, these agents carry a boxed warning and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Acute kidney injury : Can occur, particularly with dehydration from gastrointestinal side effects Diabetic retinopathy complications : Semaglutide may worsen diabetic retinopathy in patients with diabetes, particularly with rapid improvement in glucose control Severe gastrointestinal disease : Use with caution in patients with gastroparesis or severe gastrointestinal disease

Instead of its traditional injection pen products that cost more than $1,000 for a months supply, this product comes in vials that patients draw up and inject themselves
Matemu A, Nakamura S, Katayama S
Side Effect Management Both compounds have established side effect profiles from clinical trials
Yes, Glowise supports tracking for GLP-1 medications like Ozempic, Wegovy (pill & injectable), Rybelsus, and Orforglipron, including reminders, dose tracking, and symptom logging